Prognostic value of ventricular repolarization prolongation in resistant hypertension: A prospective cohort study

Journal of Hypertension

Volumn 27, Issue 5, 2009, Pages 1094-1101

  Salles, Gil F ^a,b   Cardoso, Claudia R L ^a   Muxfeldt, Elizabeth S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Electrocardiography; Morbidity; Mortality; Prognosis; Resistant hypertension

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QT INTERVAL; REPOLARIZATION;

EID: 67649644426     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832720b3     Document Type: Article

References (37)

1. Kuo CS, Reddy CP, Munakata K, Surawicz B. Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization. Eur Heart J 1985; 6:63-70.
2. Rubulis A, Jensen J, Lundahl G, Tapanainen J, Bergfeldt L. Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious interaction. J Appl Physiol 2006; 101:102-110.
3. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001; 141:334-441.
4. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The Strong Heart study. Circulation 2000; 101:61-66.
5. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS. The association between the length of the QT interval and mortality in the Cardiovascular Health study. Am J Med 2003; 115:689-694.
6. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women. The ARIC study. J Am Coll Cardiol 2004; 43:565-571.
7. Rautaharju PM, Kooperberg C, Larson JC, LaCroix A. Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women. The women's health initiative. Circulation 2006; 113:473-480.
8. Goldberg RJ, Bengtson J, Chen Z, Anderson KM, Locati E, Levy D. Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham Heart Study Experience). Am J Cardiol 1991; 67:55-58.
9. Montanez A, Ruskin JN, Hebert PR, Lamas GA, Hennekens CH. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population. Arch Intern Med 2004; 164:943-948.
10. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is 'normal'. J Cardiovasc Electrophysiol 2006; 17:333-336.
11. Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V, et al. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE study. Am Heart J 2003; 145:919-925.
12. Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens 2001; 14:455-462.
13. Schillaci G, Pirro M, Ronti T, Gemelli F, Pucci G, Innocente S, et al. Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med 2006; 166:909-913.
14. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, et al. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy. Hypertension 2004; 43:1029-1034.
15. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
16. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31:712-718.
17. Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 2005; 18:1534-1540.
18. Salles G, Leocadio S, Bloch K, Nogueira AR, Muxfeldt E. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension 2005; 46:1207-1212.
19. Salles G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Hypertension 2006; 48:437-442.
20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74.
21. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit 2000; 5:233-238.
22. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
23. Salles GF, Cardoso CR, Leocadio SM, Muxfeldt ES. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval? Am J Hypertens 2008; 21:47-53.
24. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998; 98:1928-1936.
25. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47:362-367.
26. Nilsson G, Hedberg P, Jönasson T, Lönnberg I, Öhrvik J. QTc interval and survival in 75-year-old men and women from the general population. Europace 2006; 8:233-240.
27. Sohaib SM, Papacosta O, Morris RW, Macfarlane PW, Whincup PH. Length of the QT interval: determinants and prognostic implications in a population-based prospective study of older men. J Electrocardiol 2008; 41:704-710.
28. Antzelevitch C, Shimizu W, Yan G-X, Sicouri S, Weissenburger J, Nesterenko VV, et al. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999; 10:1124-1152.
29. Passino C, Magagna A, Conforti F, Buralli S, Kosáková M, Palombo C, Emdin M. Ventricular repolarization is prolonged in nondipper hypertensive patients: role of left ventricular hypertrophy and autonomic dysfunction. J Hypertens 2003; 21:445-451.
30. Roden DM, Spooner PM. Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol 1999; 10:1664-1683.
31. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D. The Zutphen elderly study: QTc duration is associated with levels of insulin and glucose tolerance. Diabetes 1996; 45:376-380.
32. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus and cardiovascular risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001; 8:227-233.
33. Festa A, D'Agostino R, Rautaharju P, O'Leary DH, Rewers M, Mykkänen L, Haffner SM. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1999; 30:1566-1571.
34. Strohmer B, Pichler M, Iglseder B, Paulweber B. Relationship of QT interval duration with carotid intima media thickness in a clinically healthy population undergoing cardiovascular risk screening. J Intern Med 2005; 257:238-246.
35. Molnar J, Zhang F, Weiss J, Ehlert FA, Rosenthal JE. Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. J Am Coll Cardiol 1996; 27:76-83.
36. Okin PM. QT interval prolongation and prognosis: further validation of the quantitative approach to electrocardiography. J Am Coll Cardiol 2004; 43:572-575.
37. Pontiroli AE, Pizzocri P, Saibene A, Girola A, Koprivec D, Fragasso G. Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalization of blood pressure. Int J Obes Relat Metab Disord 2004; 28:1118-1123.